Vanda Pharmaceuticals
VNDA
VNDA
125 hedge funds and large institutions have $621M invested in Vanda Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 49 increasing their positions, 42 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
13% less capital invested
Capital invested by funds: $711M → $621M (-$89.8M)
48% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 25
92% less call options, than puts
Call options by funds: $768K | Put options by funds: $9.36M
Holders
125
Holding in Top 10
2
Calls
$768K
Puts
$9.36M
Top Buyers
| 1 | +$17.4M | |
| 2 | +$8.89M | |
| 3 | +$7.4M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$6.39M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$5.75M |
Top Sellers
| 1 | -$10M | |
| 2 | -$7.34M | |
| 3 | -$4.76M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$4.37M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
-$3.83M |